Estimating the Economic Impact of Radium Ra 223 Dichloride (Radium-223) in Treatment of Castration-Resistant Prostate Cancer (CRPC) with Symptomatic Bone Metastases and No Known Visceral Metastatic Disease
May 1, 2014, 00:00
10.1016/j.jval.2014.03.431
https://www.valueinhealthjournal.com/article/S1098-3015(14)00482-3/fulltext
Title :
Estimating the Economic Impact of Radium Ra 223 Dichloride (Radium-223) in Treatment of Castration-Resistant Prostate Cancer (CRPC) with Symptomatic Bone Metastases and No Known Visceral Metastatic Disease
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00482-3&doi=10.1016/j.jval.2014.03.431
First page :
A74
Section Title :
Cancer
Open access? :
No
Section Order :
1479